Weekly Injection's Real-World impact on obesity tracked in major korean study

NCT ID NCT07280221

Summary

This study is observing how well the weekly weight-loss injection Wegovy works for Korean adults with obesity in everyday medical practice. About 500 participants will receive the treatment as prescribed by their doctor, and researchers will track their weight, body composition, and health over one year. The goal is to gather real-world evidence on how effective and safe the medication is for this population.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Daejeon Endo Internal Medicine Clinic

    Daejeon, 35220, South Korea

Conditions

Explore the condition pages connected to this study.